Hazel Jones

2.4k total citations · 1 hit paper
7 papers, 1.3k citations indexed

About

Hazel Jones is a scholar working on Oncology, Psychiatry and Mental health and Cancer Research. According to data from OpenAlex, Hazel Jones has authored 7 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 2 papers in Psychiatry and Mental health and 2 papers in Cancer Research. Recurrent topics in Hazel Jones's work include Cancer, Hypoxia, and Metabolism (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Hazel Jones is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Hazel Jones collaborates with scholars based in United Kingdom, Australia and Canada. Hazel Jones's co-authors include Eleanor J. Cheadle, Robert W. Wilkinson, Conor McKenna, Grazyna Lipowska‐Bhalla, Michelle Morrow, Edmund Poon, Amy L. Adlard, Ross Stewart, Tim Illidge and Jamie Honeychurch and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Hazel Jones

7 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade

2014 974 citations Simon J. Dovedi, Amy L. Adlard et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hazel Jones United Kingdom	4	925	432	409	168	155	7	1.3k
Anna Wilkins United Kingdom	16	640 0.7×	400 0.9×	430 1.1×	167 1.0×	340 2.2×	39	1.3k
Martin Donach Italy	14	606 0.7×	279 0.6×	275 0.7×	58 0.3×	151 1.0×	30	1.1k
Julian A. Marin‐Acevedo United States	13	1.1k 1.2×	358 0.8×	732 1.8×	131 0.8×	354 2.3×	27	1.7k
Hampartsoum B. Barsoumian United States	25	937 1.0×	425 1.0×	709 1.7×	150 0.9×	426 2.7×	57	1.6k
Alex Chehrazi‐Raffle United States	11	869 0.9×	331 0.8×	461 1.1×	65 0.4×	374 2.4×	64	1.3k
Amandine Alard United States	10	851 0.9×	315 0.7×	724 1.8×	80 0.5×	576 3.7×	13	1.6k
Magnus T. Dillon United Kingdom	15	700 0.8×	271 0.6×	408 1.0×	132 0.8×	534 3.4×	23	1.3k
Pushpamali De Silva Belgium	21	708 0.8×	286 0.7×	478 1.2×	140 0.8×	211 1.4×	36	1.1k
Andrew L. Coveler United States	22	1.1k 1.2×	244 0.6×	607 1.5×	132 0.8×	481 3.1×	105	1.7k
Shuhua Wei China	12	443 0.5×	195 0.5×	559 1.4×	128 0.8×	347 2.2×	21	1.1k

Countries citing papers authored by Hazel Jones

Since Specialization

Citations

This map shows the geographic impact of Hazel Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hazel Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hazel Jones more than expected).

Fields of papers citing papers by Hazel Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hazel Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hazel Jones. The network helps show where Hazel Jones may publish in the future.

Co-authorship network of co-authors of Hazel Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Hazel Jones. A scholar is included among the top collaborators of Hazel Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hazel Jones. Hazel Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Ireson, Christopher R., Mohammad S. Alavijeh, Alan M. Palmer, Emily Fowler, & Hazel Jones. (2019). The role of mouse tumour models in the discovery and development of anticancer drugs. British Journal of Cancer. 121(2). 101–108. 138 indexed citations

2.

Jones, Robert H., David Alan Anthoney, Robert J. Jones, et al.. (2016). FIESTA: A phase Ib and pharmacokinetic trial of AZD4547 in combination with gemcitabine and cisplatin.. Journal of Clinical Oncology. 34(15_suppl). 4521–4521. 2 indexed citations

3.

Jones, Hazel. (2016). Ethical considerations in the use of student data. ASCILITE Publications. 300–304. 1 indexed citations

4.

Dovedi, Simon J., Amy L. Adlard, Grazyna Lipowska‐Bhalla, et al.. (2014). Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade. Cancer Research. 74(19). 5458–5468. 974 indexed citations breakdown →

5.

Dovedi, Simon J., Amy L. Adlard, Grazyna Lipowska‐Bhalla, et al.. (2014). The anti-tumor immune response generated by radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade. Journal for ImmunoTherapy of Cancer. 2(S3). 3 indexed citations

6.

Wang, Shouming, Adrian Folkes, Irina Chuckowree, et al.. (2004). Studies on Pyrrolopyrimidines as Selective Inhibitors of Multidrug-Resistance- Associated Protein in Multidrug Resistance. Journal of Medicinal Chemistry. 47(6). 1329–1338. 69 indexed citations

7.

Jones, Hazel, David I. Vernon, & Stanley B. Brown. (2003). Photodynamic therapy effect of m-THPC (Foscan®) in vivo: correlation with pharmacokinetics. British Journal of Cancer. 89(2). 398–404. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact